Tandem Mobi System

Over the coming weeks, Tandem Mobi users will receive an email letting them know that this software update is available.

Software Version 7.7

What's New

This software update allows you to choose which continuous glucose monitoring (CGM)* sensor to integrate with your Tandem Mobi system.

Dexcom G7

This software version of Tandem Mobi is compatible with specific versions of the Dexcom G7 sensor.

Dexcom G6

This software version of Tandem Mobi is compatible with all versions of the Dexcom G6 sensor.

Before You Update

You must complete the required online training in your Tandem Source platform account before you can initiate the pump software update.

Choose a convenient time when you have supplies on hand and can stop all insulin delivery. You will need to disconnect your infusion set during the update and load a cartridge to resume insulin delivery.

Tandem Mobi System Software Update Status

Confirm your eligibility for this software update^†

Log in Now

Responsible Use of Control‑IQ Technology

Even with advanced systems such as Control-IQ technology, you are still responsible for actively managing your diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires your accurate input of information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless you use all system components, including your CGM, infusion sets and pump cartridges, as instructed. Importantly, the system cannot adjust your insulin dosing if the pump is not receiving CGM readings. Because there are situations and emergencies that the system may not be capable of identifying or addressing, always pay attention to your symptoms and treat according to your healthcare provider’s recommendations.

* CGM sold separately.

† Software updates are only available to customers who have in-warranty pumps at the time they update their software. They may also require a prescription and additional training. Charges may apply. Tandem may discontinue select software and features over time at its discretion.

Important Safety Information

RX ONLY.

Indications for Use

Tandem Mobi insulin pump with interoperable technology: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use in individuals 6 years of age and greater.

Control-IQ technology: Control-IQ technology is intended for use with a compatible iCGM (sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons 6 years of age and greater. Control-IQ technology is intended for single patient use. Control IQ-technology is indicated for use with NovoLog or Humalog U-100 insulin.

Warning: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of a Tandem insulin pump and Control-IQ technology must use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The Tandem pump, and the CGM transmitter (when applicable) and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

The Tandem Source platform is intended for use by individuals with diabetes mellitus who use Tandem Diabetes Care insulin pumps, their caregivers, and their healthcare providers in home and clinical settings. The Tandem Source platform supports diabetes management through the display and analysis of information uploaded from Tandem insulin pumps.

Tandem Mobi System

Software Version 7.7

Before You Update

Confirm your eligibility for this software update^†

Positively Different

Connected Care

Disclosures

Tandem Mobi System

Software Version 7.7

Before You Update

Confirm your eligibility for this software update†

Confirm your eligibility for this software update^†